Concepedia

James L. Shellhaas

JL

3

Publications

424

Citations

3

H-Index

1989

Active since

Affiliations

Eli Lilly (United States)(Current)

James L. Shellhaas is an author at Eli Lilly (United States) specializing in immunology, medicine, and cell death.

Top concepts

MedicineImmunologyCell DeathCell BiologyInflammationEndocrinologyCell SignalingImmune FunctionImmune RegulationHealth

Publications per year

1989–1995

3

Publications

3

Differential regulation of lipopolysaccharide‐induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axis

Steven H. Zuckerman, James L. Shellhaas, Larry D. Butter · European Journal of Immunology · 1989 · 325 citations

Lipopolysaccharide‐induced Interleukin 1, Immunology, Immune Regulation +21

Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-α

Larry Butler, Nicolette K. Layman, Pamela E. Riedl et al. · Journal of Neuroimmunology · 1989 · 83 citations

Immune Regulation, Immunology, Renal Inflammation +16

In vitro detection of apoptotic stimuli by use of the HL-60 myeloid leukemic cell line

James L. Shellhaas, Steven H. Zuckerman · Clinical and Diagnostic Laboratory Immunology · 1995 · 16 citations · Full text

Apoptosis, Immunology, Cell Death +18

Rows per page

1–3 of 3